MedTrace Logo

MELT - MRI Evaluation of Lymphoma Treatment

NCT01459224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2015-12-03

No results posted yet for this study

Summary

Patients who are newly diagnosed with Hodgkin's lymphoma will undergo disease staging at diagnosis and initial treatment response assessment. At each time point (initial staging and treatment response assessment) in addition to standard imaging investigations (PET CT, Chest CT, anatomical MRI of the abdomen and pelvis and abdominal USS), patients will undergo an extended MRI scan.

Conditions

  • Lymphoma, Hodgkin

Sponsors & Collaborators

  • University College, London

    lead OTHER

Principal Investigators

  • Stuart A Taylor, Prof · UCLH

Eligibility

Min Age
5 Years
Max Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2014-09-30
Completion
2015-10-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01459224 on ClinicalTrials.gov